Cargando…

Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection

BACKGROUND: It has been shown previously that administration of Francisella tularensis (Ft) Live Vaccine Strain (LVS) lipopolysaccharide (LPS) protects mice against subsequent challenge with Ft LVS and blunts the pro-inflammatory cytokine response. METHODS: To further investigate the molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohapatra, Saroj K, Cole, Leah E, Evans, Clive, Sobral, Bruno W, Bassaganya-Riera, Josep, Hontecillas, Raquel, Vogel, Stefanie N, Crasta, Oswald R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826305/ https://www.ncbi.nlm.nih.gov/pubmed/20082697 http://dx.doi.org/10.1186/1471-2334-10-10

Ejemplares similares

The capBCA Locus is Required for Intracellular Growth of Francisella tularensis LVS
por: Su, Jingliang, et al.
Publicado: (2011)

The role of MglA for adaptation to oxidative stress of Francisella tularensis LVS
por: Honn, Marie, et al.
Publicado: (2012)

Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness
por: Biot, Fabrice V., et al.
Publicado: (2020)

Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate
por: Kim, Eun-Ju, et al.
Publicado: (2008)

Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages
por: Bradford, Mary Katherine, et al.
Publicado: (2020)

A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS
por: Ashtekar, Amit R., et al.
Publicado: (2012)

Francisella tularensis LVS Surface and Membrane Proteins as Targets of Effective Post-Exposure Immunization for Tularemia
por: Chandler, Jeffrey C., et al.
Publicado: (2014)

Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)
por: Twine, Susan M., et al.
Publicado: (2010)

IKKβ in Myeloid Cells Controls the Host Response to Lethal and Sublethal Francisella tularensis LVS Infection
por: Samaniego, Sylvia, et al.
Publicado: (2013)

IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice
por: Mittereder, Lara R., et al.
Publicado: (2023)

Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections
por: Robinson, Cory M, et al.
Publicado: (2015)

The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection
por: Lindgren, Marie, et al.
Publicado: (2013)

Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS
por: Chen, Fei, et al.
Publicado: (2017)

Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle
por: Freudenberger Catanzaro, Kelly C., et al.
Publicado: (2022)

Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon γ Receptors
por: Cowley, Siobhán C., et al.
Publicado: (2003)

IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS
por: Kurtz, Sherry L., et al.
Publicado: (2014)

Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo
por: Honn, Marie, et al.
Publicado: (2017)

Atg5-Deficient Mice Infected with Francisella tularensis LVS Demonstrate Increased Survival and Less Severe Pathology in Internal Organs
por: Kelava, Ina, et al.
Publicado: (2020)

PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS
por: Cantlay, Stuart, et al.
Publicado: (2022)

Production of Anti-LPS IgM by B1a B Cells Depends on IL-1β and Is Protective against Lung Infection with Francisella tularensis LVS
por: del Barrio, Laura, et al.
Publicado: (2015)

The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence
por: Pérez, Natalie Marie, et al.
Publicado: (2014)

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates
por: Post, Deborah M. B., et al.
Publicado: (2017)

Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity
por: Kurtz, Sherry L., et al.
Publicado: (2021)

A human macrophage – hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica
por: Rennert, Knut, et al.
Publicado: (2016)

Use of a Capture-Based Pathogen Transcript Enrichment Strategy for RNA-Seq Analysis of the Francisella Tularensis LVS Transcriptome during Infection of Murine Macrophages
por: Bent, Zachary W., et al.
Publicado: (2013)

Models Derived from In Vitro Analyses of Spleen, Liver, and Lung Leukocyte Functions Predict Vaccine Efficacy against the Francisella tularensis Live Vaccine Strain (LVS)
por: De Pascalis, Roberto, et al.
Publicado: (2014)

Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge
por: McCormick, Alison A., et al.
Publicado: (2018)

Stabilising all Kähler moduli in perturbative LVS
por: Leontaris, George K., et al.
Publicado: (2022)

Development of Functional and Molecular Correlates of Vaccine-Induced Protection for a Model Intracellular Pathogen, F. tularensis LVS
por: De Pascalis, Roberto, et al.
Publicado: (2012)

DotU and VgrG, Core Components of Type VI Secretion Systems, Are Essential for Francisella LVS Pathogenicity
por: Bröms, Jeanette E., et al.
Publicado: (2012)

A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia
por: Golovliov, Igor, et al.
Publicado: (2013)

Protective Immunity against Lethal F. tularensis holarctica LVS Provided by Vaccination with Selected Novel CD8(+) T Cell Epitopes
por: Rotem, Shahar, et al.
Publicado: (2014)

The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease
por: Guri, Amir J, et al.
Publicado: (2010)

Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9
por: De Pascalis, Roberto, et al.
Publicado: (2020)

The Human-Bacterial Pathogen Protein Interaction Networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis
por: Dyer, Matthew D., et al.
Publicado: (2010)

Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing
por: Jaing, Crystal J., et al.
Publicado: (2016)

TLR2 Signaling is Required for the Innate, but Not Adaptive Response to LVS clpB
por: Roberts, Lydia M., et al.
Publicado: (2014)

Ypt4 and lvs1 regulate vacuolar size and function in Schizosaccharomyces pombe
por: Rains, Addison, et al.
Publicado: (2017)

Deletion Mutants of Francisella Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal Francisella LVS Challenge in a Murine Model of Respiratory Tularemia
por: Hobbs, Brandi E., et al.
Publicado: (2021)

Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists
por: Bassaganya-Riera, Josep, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s2t376rkq2r9hqv4sc4esvqfua